LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

Search

Quanterix Corp

Abrir

SetorSaúde

6.59 3.13

Visão Geral

Variação de preço das ações

24h

Atual

Mín

6.34

Máximo

6.78

Indicadores-chave

By Trading Economics

Rendimento

-3.5M

-34M

Vendas

16M

40M

Margem de lucro

-83.479

Funcionários

471

EBITDA

5.7M

-31M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+19.24% upside

Dividendos

By Dow Jones

Próximos Ganhos

2 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

27M

265M

Abertura anterior

3.46

Fecho anterior

6.59

Sentimento de Notícias

By Acuity

17%

83%

19 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

Quanterix Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de fev. de 2026, 22:04 UTC

Ganhos

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26 de fev. de 2026, 23:55 UTC

Conversa de Mercado

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26 de fev. de 2026, 23:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26 de fev. de 2026, 23:37 UTC

Conversa de Mercado

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26 de fev. de 2026, 23:32 UTC

Ganhos

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26 de fev. de 2026, 23:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 de fev. de 2026, 23:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 de fev. de 2026, 23:12 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Global Equities Roundup: Market Talk

26 de fev. de 2026, 23:12 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26 de fev. de 2026, 23:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 de fev. de 2026, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 de fev. de 2026, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 de fev. de 2026, 22:55 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 de fev. de 2026, 22:43 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

26 de fev. de 2026, 22:43 UTC

Conversa de Mercado

RBA Hike In March Is Being Underpriced -- Market Talk

26 de fev. de 2026, 22:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 de fev. de 2026, 22:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 de fev. de 2026, 22:13 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26 de fev. de 2026, 21:59 UTC

Ganhos

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26 de fev. de 2026, 21:58 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

26 de fev. de 2026, 21:49 UTC

Ganhos

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26 de fev. de 2026, 21:45 UTC

Ganhos

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26 de fev. de 2026, 21:44 UTC

Ganhos

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26 de fev. de 2026, 21:44 UTC

Ganhos

Coles Expects Market to Remain Highly Competitive

26 de fev. de 2026, 21:44 UTC

Ganhos

Coles Says Supermarket Customers Remain Value Oriented

26 de fev. de 2026, 21:43 UTC

Ganhos

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26 de fev. de 2026, 21:43 UTC

Ganhos

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26 de fev. de 2026, 21:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26 de fev. de 2026, 21:41 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Comparação entre Pares

Variação de preço

Quanterix Corp Previsão

Preço-alvo

By TipRanks

19.24% parte superior

Previsão para 12 meses

Média 7.5 USD  19.24%

Máximo 8 USD

Mínimo 7 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Quanterix Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

2 ratings

0

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

5.34 / 6.015Suporte e Resistência

Curto Prazo

Neutral Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

19 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat